Nathan Williams
The hiring of ex-WIL Research Company chief executive David Spaight comes one week after the New York-based healthcare and industrials investor closed a $1.3bn fund.
BC Partners has bought 22 Priory Group hospitals from Acadia Healthcare Group for around £300 million in a deal spurred by a competition investigation.
Arsenal Capital Partners raised the fund in a little over a year as a successor to its Fund III, which is currently booking a strong internal rate of return.
Californian venture firm General Catalyst has led a $45M investment in genetic testing company Color Genomics, a round also supported by the singer Bono.
CVC Capital Partners has sold Quironsalud, Spain’s largest private hospital operator, to German healthcare provider Fresenius.
The deal for the medical products manufacturer comes as the US buyout firm explores LP appetite for a tenth fund which could target at least $8bn.
Cinven has acquired clinical trials services provider Bioclinica from US private equity firms Water Street Healthcare Partners and JLL Partners.
The sale comes as Kainos continues to amass capital for its second fund, targeting $750m.
Italian buyout house Charme Capital Partners has acquired a genetic testing company from its third fund, which has exceeded its €500m target.
Malaysia-based private equity firm Navis Capital Partners has acquired a stake in Tawada Healthcare, one of the largest medical device distributors in Indonesia.